Brief: Nanoform, Nacuity Pharmaceuticals Sign Agreement For Ophthalmic Drug Candidates

Nanoform Finland Oyj

31/03/2021 06:18

March 31 (Reuters) - Nanoform Finland Plc  NANOFH.HE :
    * CO AND NACUITY PHARMACEUTICALS SIGN TECHNOLOGY PROOF OF CONCEPT AGREEMENT FOR TWO
OPHTHALMIC
DRUG CANDIDATES
    * WORK WILL EXPLORE FEASIBILITY OF PATENTED CESS PROCESS TO PRODUCE NANOPARTICLES OF BOTH
MOLECULES IN AN EFFORT TO ENHANCE OPHTHALMIC DRUG DELIVERY

Source text for Eikon:  ID:nWkr9N5g8L 
Further company coverage:  NANOFH.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))